AA
AMGN icon

Advisory Advocates’s Amgen AMGN Stock Holding History

Advisory Advocates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$791K Sell
2,185
-216
-9% -$73.9K 0.68% 35
2026
Q1 		$845K Sell
2,401
-474
-16% -$169K 0.86% 34
2025
Q4 		$941K Buy
+2,875
New +$912K 0.94% 30

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Advisory Advocates's AMGN Position: Q2 2026 in Review

Advisory Advocates reduced its Amgen (AMGN) stake by 9% in Q2 2026, selling an estimated $73.9K and leaving 2,185 shares worth $791K. The position accounts for 0.68% of the portfolio, ranked #35.

Advisory Advocates first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $941K in Q4 2025. 3,029 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Advisory Advocates held 2,185 shares of Amgen worth $791K as of Q2 2026.
  • Advisory Advocates sold 216 Amgen shares in Q2 2026, an estimated $73.9K.
  • Amgen made up 0.68% of Advisory Advocates's portfolio in Q2 2026, its #35 holding.
  • Advisory Advocates first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • Advisory Advocates's Amgen position peaked at $941K in Q4 2025.
  • 3,029 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Advisory Advocates's 13F filing for Q2 2026, filed 10 Aug 2026.